OCD & Anxiety Interactive Interpreter

BDD Test (Body Dysmorphic Disorder)

BDD screening test using the BDDQ (Body Dysmorphic Disorder Questionnaire). BDD-YBOCS severity interpretation (0–48), BDD behaviors, and comparison with OCD and eating disorders. Phillips (1996).

Try the Interpreter

BDD-YBOCS Score Interpreter

Moderate

Moderate severity; clinical care typically indicated.

12-item semi-structured clinician-administered interview. Each item rated 0–4. Higher scores = greater severity. Requires a trained clinician; not for self-scoring.

Total scoreInterpretation
37+ExtremeExtreme severity; associated with marked functional impairment.
30–36SevereSevere BDD symptoms with significant distress and interference.
24–29ModerateModerate severity; clinical care typically indicated.
0–23MildMild severity. Note: all cutoff data derived from clinical populations — a low score does not rule out BDD.

Phillips et al. 1997 (PMID 9133747); severity bands per Mataix-Cols et al. 2025 (PMID 40578059), derived from ROC analysis in 804 clinical participants. Educational reference only — not a diagnostic tool.

A BDD screening test based on the BDDQ (Body Dysmorphic Disorder Questionnaire), a validated brief screener for body dysmorphic disorder. Includes BDD-YBOCS severity interpretation and complete guide to BDD diagnosis and treatment. Phillips (1996).

What is Body Dysmorphic Disorder?

Body Dysmorphic Disorder (BDD) is a DSM-5-TR obsessive-compulsive spectrum disorder characterized by persistent preoccupation with one or more perceived flaws or defects in physical appearance that are not observable or appear slight to others. These preoccupations cause significant distress and lead to repetitive behaviours (checking, seeking reassurance, camouflaging) or mental acts that are difficult to control.

BDD affects approximately 1.7–2.4% of the general population and is equally common in men and women. Skin, hair, and nose are among the most commonly preoccupying body areas, though any body part can become the focus — and many individuals are concerned with multiple areas simultaneously. BDD is associated with high psychiatric comorbidity (depression, social anxiety, OCD) and significantly elevated suicide risk; suicide attempt rates in clinical samples are substantially elevated compared to the general population.

BDD is frequently misdiagnosed or missed in clinical settings, partly because patients often present to dermatology or cosmetic surgery rather than mental health. Evidence-based treatments include CBT with exposure and response prevention (ERP) specifically targeting BDD-related rituals, and SSRIs at higher doses than typically used for depression.

BDD Screening Questions (BDDQ)

Based on the BDDQ (Body Dysmorphic Disorder Questionnaire). Answer honestly; this screening does not diagnose BDD.

BDD-YBOCS Severity Reference

The BDD-YBOCS (Phillips et al., 1997) is the standard clinician-administered severity measure for BDD in clinical trials and outcome monitoring. The 12-item semi-structured interview assesses time occupied by preoccupation, distress, interference with functioning, resistance, and degree of control — evaluated separately for appearance-related thoughts and for BDD behaviours. Each item is scored 0–4, giving a total range of 0–48.

BDD-YBOCS Total (0–48)

A 2025 multi-site study by Mataix-Cols et al. (n = 804 clinical participants) used receiver-operating characteristic (ROC) analyses against the Clinical Global Impressions–Severity scale to derive the first empirically-supported severity cutoffs for the BDD-YBOCS:

Score rangeSeverity categoryNotes
37–48ExtremeMarked functional impairment; highest tier
30–36SevereSignificant distress and interference
24–29ModerateClinical care typically indicated
0–23MildStill within the clinical range; all cutoff data come from clinical samples

These bands were consistent across sexes, age groups, and participants from Europe and the United States. The authors note that the cutoff for distinguishing clinical from subclinical BDD was not computable because all participants in the pooled dataset were clinical cases; a low score should not be interpreted as ruling out BDD.

The BDD-YBOCS factor structure comprises two weakly correlated subfactors: a Severity factor (time, distress, interference, avoidance; α = 0.82; strong construct validity with BDD impairment measures) and a Resistance/Control factor (effort to resist symptoms, control over symptoms; α = 0.74; more limited external validity). Clinicians tracking treatment response should note that these subfactors may change independently.

Common BDD Behaviors

BDD is defined in part by repetitive, time-consuming behaviours or mental acts performed in response to appearance-related preoccupations. These are analogous to compulsions in OCD but focused on perceived physical defects. Common behaviours documented in clinical samples include:

  • Mirror checking — repeatedly examining the perceived flaw in mirrors or reflective surfaces; some individuals alternate between excessive checking and mirror avoidance
  • Camouflaging — using clothing, makeup, hats, or specific postures to conceal the perceived defect
  • Reassurance seeking — repeatedly asking others whether the perceived flaw is noticeable
  • Skin picking — excoriation directed at the preoccupied area (e.g. acne-related picking that worsens skin appearance)
  • Comparing — measuring or comparing the perceived flaw against those of others in person or via social media
  • Excessive grooming — prolonged hair styling, shaving, or applying makeup to correct or minimize the perceived defect
  • Seeking cosmetic procedures — consulting dermatologists, plastic surgeons, or dentists; typically provides little or no lasting relief
  • Avoidance behaviours — avoiding social situations, work, or photography due to fear of being noticed

These behaviours are often ego-dystonic (experienced as unwanted), distinguishing them from grooming or hygiene routines. They typically consume one or more hours per day and can occupy much of the waking day in severe presentations.

BDD shares surface features with several other disorders, and co-occurrence is common. Understanding the key distinctions guides accurate differential diagnosis.

BDD vs OCD: Both are classified as obsessive-compulsive and related disorders in DSM-5-TR. BDD preoccupations are exclusively focused on physical appearance, whereas OCD obsessions centre on harm, contamination, symmetry, or forbidden thoughts. In a direct comparison of 34 BDD and 79 OCD patients, both groups showed similar sex ratios, but BDD patients had earlier onset and lower rates of employment. BDD and OCD co-occur in a meaningful subset of patients; when both are present, the comorbid group shows higher rates of social phobia and eating disorder comorbidity, and overall psychopathology and functional impairment tend to be more severe. Insight is often poorer in BDD — a significant proportion of BDD patients hold their appearance-related convictions with delusional intensity, which is less common in typical OCD presentations.

BDD vs eating disorders: Both conditions involve distressing preoccupation with body image and can share behaviours such as mirror checking and avoidance. The key distinction is focus: BDD preoccupation targets a specific perceived defect (nose shape, skin texture, facial asymmetry), while eating disorder preoccupation centres on weight, shape, and calorie intake. Weight and shape can also be a focus of BDD, which can make the differential challenging; the presence of marked dietary restriction and weight-related compensatory behaviours generally points toward an eating disorder diagnosis. Co-occurrence of BDD with eating disorders is higher than chance.

BDD vs social anxiety disorder: Both conditions involve significant social avoidance driven by fear of negative evaluation. In BDD, avoidance is specifically tied to the feared visibility of the perceived physical defect; in social anxiety disorder, avoidance is broader and not anchored to appearance concerns. BDD is associated with higher rates of cosmetic treatment-seeking, skin picking, and mirror behaviours that are not features of social anxiety disorder.

OCD-Spectrum Outcome Tracking

BDD-YBOCS, OCI-R, Y-BOCS, and EDE-Q — integrated OCD-spectrum and eating disorder outcome monitoring for outpatient and IOP programs.

Clinical Use:These results are intended to inform clinical decision-making in licensed practice. They do not replace evaluation by a qualified clinician.

References

  1. 1.
    Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, Goodman WK. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull. 1997;33(1):17-22.View source
  2. 2.
    Mataix-Cols D, Andersson P, Rautio D, et al. Empirically informed symptom severity cutoffs for body dysmorphic disorder. J Psychiatr Res. 2025;189:382-387.View source
  3. 3.
    Snorrason I, Jaroszewski AC, Greenberg JL, et al. Yale-Brown Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder: Factor structure and construct validity of subfactors. J Obsessive Compuls Relat Disord. 2024;42:100881.View source
  4. 4.
    Frare F, Perugi G, Ruffolo G, Toni C. Obsessive-compulsive disorder and body dysmorphic disorder: a comparison of clinical features. Eur Psychiatry. 2004;19(5):292-298.View source

Frequently Asked Questions

What does a BDD-YBOCS score mean?

The BDD-YBOCS is a 12-item clinician-administered interview scored 0–48. A 2025 study using data from 804 clinical participants found that scores of 0–23 indicate mild, 24–29 moderate, 30–36 severe, and 37 or above extreme severity. Because all participants in that dataset were clinical cases, a low score does not rule out BDD — the scale is used to track severity, not to screen for the disorder.

Is the BDD-YBOCS self-report or clinician-administered?

The BDD-YBOCS is a semi-structured clinician-administered interview, not a self-report questionnaire. A trained clinician rates each item based on the patient's responses. The BDDQ (Body Dysmorphic Disorder Questionnaire) is the brief self-report screener used for initial detection.

Can the BDDQ diagnose body dysmorphic disorder?

No. The BDDQ is a screening tool designed to flag individuals who may have BDD and warrant further clinical evaluation. A positive screen indicates the need for a comprehensive assessment by a qualified clinician; it is not sufficient for a diagnosis on its own.

How is BDD different from OCD?

Both BDD and OCD are classified as obsessive-compulsive spectrum disorders in DSM-5-TR and share features such as intrusive, distressing preoccupations and repetitive behaviours performed to reduce anxiety. The key distinction is content: OCD obsessions typically concern harm, contamination, or symmetry, while BDD preoccupations are specifically focused on perceived physical defects. BDD also shows higher rates of comorbid social anxiety and tends to onset at a younger age than OCD.